SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001554795-24-000032
Filing Date
2024-03-04
Accepted
2024-03-04 12:38:05
Documents
15
Period of Report
2023-11-30
Items
Item 4.01: Changes in Registrant's Certifying Accountant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K cncl0301form8k.htm   iXBRL 8-K 25561
  Complete submission text file 0001554795-24-000032.txt   224330

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE cncl-20231130.xsd EX-101.SCH 3049
3 XBRL DEFINITION FILE cncl-20231130_def.xml EX-101.DEF 26155
4 XBRL LABEL FILE cncl-20231130_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE cncl-20231130_pre.xml EX-101.PRE 22343
17 EXTRACTED XBRL INSTANCE DOCUMENT cncl0301form8k_htm.xml XML 3607
Mailing Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106
Business Address 2157 S. LINCOLN SUITE 200 SALT LAKE CITY UT 84106 801-323-2395
CANCER CAPITAL CORP (Filer) CIK: 0001130889 (see all company filings)

IRS No.: 911803648 | State of Incorp.: WY | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-32363 | Film No.: 24713895
SIC: 6770 Blank Checks
(CF Office: 05 Real Estate & Construction)